Allogenic T Cell Immunotherapy in Development for Progressive Focal Leukoencephalopathy
A novel allogeneic T cell-based immunotherapy, CE-VST01-JC, for progressive focal...
Read MoreMay 15, 2023
A novel allogeneic T cell-based immunotherapy, CE-VST01-JC, for progressive focal...
Read MoreMay 15, 2023
In basilar artery occlusion, endovascular thrombectomy within 12 hours of onset improved...
Read MoreMay 15, 2023
Continuous levodopa/carbidopa infusion had a good safety profile and was well-tolerated...
Read MoreMay 15, 2023
More patients with early symptomatic AD achieved amyloid clearance and plaque reductions at 6...
Read MoreMay 15, 2023
In a big-data analysis of 25 acute migraine medications, triptans, ergots, and anti-emetics...
Read MoreMay 15, 2023
In ELEVATE, atogepant was effective in preventing difficult-to-treat episodic migraine among...
Read MoreMay 15, 2023
Sphingosine kinase 2 may be a promising clinical target for overcoming EGFR-TKI resistance and...
Read MoreMay 15, 2023
More often, it seems that hospitals and CME providers are offering resiliency training courses to...
Read MoreMay 10, 2023
A couple of months ago, I went to Home Depot to return a rented carpet cleaner. Going into the...
Read MoreMay 9, 2023
The use of high sensitivity DNA sequencing tests to measure residual disease in AML could improve...
Read MoreMay 8, 2023
The SELECT2 trial showed superior outcomes with endovascular thrombectomy plus medical care...
Read MoreMay 8, 2023
Ravulizumab reduced relapse risk and Hauser Ambulation Index score worsening versus placebo in...
Read MoreMay 8, 2023
In a phase 3 study, pridopidine did not meet its primary endpoint in patients with Huntington’s...
Read MoreMay 8, 2023
Intrathecal mesenchymal stem cell-neural progenitor therapy failed to significantly improve the...
Read MoreMay 8, 2023
The VISIONARY-MS study suggests catalytically active gold nanocrystals given in addition to...
Read MoreMay 8, 2023
In people with radiologically isolated syndrome, teriflunomide resulted in a 62% risk decline for...
Read MoreMay 8, 2023
Spinal cord stimulation provides durable pain relief for diabetic neuropathy with an acceptable...
Read MoreMay 8, 2023
In CLARITY AD, lecanemab slowed decline in measures of cognition and function and reduced markers...
Read MoreMay 8, 2023
“Original antigenic sin” may play a role in the humoral immune response to SARS-CoV-2 immunity and...
Read MoreMay 8, 2023
Zavegepant nasal spray was effective for acute migraine, demonstrating onset of efficacy as early...
Read More